SMARCA5/SNF2H Recombinant Enzymes

• Reactivity: Hu
• Applications: NULL

SMARCA5/SNF2H Recombinant Enzymes Summary

• Description: Human SNF2H (aa 2-1052) fused to a FLAG-tag at the N-terminus. (Uniprot: O60264)
• Source: Sf 9 (baculovirus)
• Protein/Peptide Type: Recombinant Enzymes
• Gene: SMARCA5
• Purity: Immunogen affinity purified

Applications/Dilutions

• Dilutions:
  • N/A

Packaging, Storage & Formulations

• Storage: Store at -80C. Avoid freeze-thaw cycles.
• Buffer: 20 mM Tris-HCl, pH 7.9, 150 mM NaCl, 15% glycerol, 2 mM MgCl2, 0.2 mM EDTA, 1 mM DTT, 10 mM beta-glycerophospate, 0.4 mM PMSF, 1 mM benzamidine and 0.4 mg/ml recombinant human insulin
• Preservative: No Preservative
• Purity: Immunogen affinity purified

Alternate Names for SMARCA5/SNF2H Recombinant Enzymes

• EC 3.6.1
• EC 3.6.4.-
• hISWI
• hSNF2HSWI/SNF-related matrix-associated actin-dependent regulator of chromatin A5
• ISWI
• SMARCA5
• SNF2H
• SNF2Hsucrose nonfermenting-like 5
• subfamily a, member 5
• Sucrose nonfermenting protein 2 homolog
• SWI/SNF related, matrix associated, actin dependent regulator of chromatin
• SWI/SNF-related matrix-associated actin-dependent regulator of chromatinsubfamily A member 5
• WCRF135

Background

The SWI/SNF-related, matrix-associated, actin-dependent regulators of chromatin (SMARC), also called BRG1-associated factors (BAFs), have been identified as components of the human SWI/SNF-like chromatin-remodeling protein complexes. SNF2h/ISWI, also known as WCRF135, is the gene product of SMARCA5 that associates with WSTF (Williams Syndrome transcription factor) and several other nuclear proteins to mediate chromatin remodeling. SNF2h is also part of the NoRC (nucleolar remodeling complex).

Limitations

This product is for research use only and is not approved for use in humans or in clinical diagnosis. Peptides and proteins are guaranteed for 3 months from date of receipt.

Bioinformatics

• Gene Symbol: SMARCA5